With minimal sample and reagent volume requirements,
and ability to use whole blood samples with on-chip plasma separation,
digital microfluidics multiplex assays for TSB and G6PD
have potential to be a point-of-care diagnostic tool ideal
for universal screening and emerging national health screening programs.